Skip to main content

Larimar Therapeutics, Inc.

LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374690

In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Larimar Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
136
+21 vs. Q2 2025
Shares held
85.5M
+23.4M (+37.7%) vs. Q2 2025
Total value
$274.8M
+$95.4M (+53.2%) vs. Q2 2025
New holders
30
60 more added
Sold out
9
26 more reduced

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 136 institutions
Q1 2021: 57 institutionsQ2 2021: 45 institutionsQ3 2021: 54 institutionsQ4 2021: 49 institutionsQ1 2022: 45 institutionsQ2 2022: 40 institutionsQ3 2022: 59 institutionsQ4 2022: 48 institutionsQ1 2023: 69 institutionsQ2 2023: 65 institutionsQ3 2023: 65 institutionsQ4 2023: 69 institutionsQ1 2024: 104 institutionsQ2 2024: 107 institutionsQ3 2024: 123 institutionsQ4 2024: 116 institutionsQ1 2025: 103 institutionsQ2 2025: 116 institutionsQ3 2025: 136 institutionsQ4 2025: 136 institutionsQ1 2026: 162 institutionsQ2 2026: 163 institutions
Value heldQ3 2025: $274.8M
Q1 2021: $206.1MQ2 2021: $142.8MQ3 2021: $167.5MQ4 2021: $157.2MQ1 2022: $61.8MQ2 2022: $28.2MQ3 2022: $123.9MQ4 2022: $160.1MQ1 2023: $174.2MQ2 2023: $120.2MQ3 2023: $153.0MQ4 2023: $179.6MQ1 2024: $482.8MQ2 2024: $473.5MQ3 2024: $421.3MQ4 2024: $245.5MQ1 2025: $131.9MQ2 2025: $180.1MQ3 2025: $274.8MQ4 2025: $277.0MQ1 2026: $394.8MQ2 2026: $291.4M
Institutions holding LRMR and their total value by quarter
QuarterHoldersValue
Q2 2026163$291.4M
Q1 2026162$394.8M
Q4 2025136$277.0M
Q3 2025136$274.8M
Q2 2025116$180.1M
Q1 2025103$131.9M
Q4 2024116$245.5M
Q3 2024123$421.3M
Q2 2024107$473.5M
Q1 2024104$482.8M
Q4 202369$179.6M
Q3 202365$153.0M
Q2 202365$120.2M
Q1 202369$174.2M
Q4 202248$160.1M
Q3 202259$123.9M
Q2 202240$28.2M
Q1 202245$61.8M
Q4 202149$157.2M
Q3 202154$167.5M
Q2 202145$142.8M
Q1 202157$206.1M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding LRMR in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
J. Goldman & Co LP203,724$658.0K0.02%+203,724New
Simplex Trading, LLC215,462$695.0K0.02%+75,038+53.4%Added
ADAR1 Capital Management, LLC235,689$761.3K0.08%−1,916−0.8%Reduced
Cerity Partners LLC239,146$772.4K0.00%+18,945+8.6%Added
Two Sigma Advisers, LP252,371$815.2K0.00%−894,553−78.0%Reduced
UBS Group AG257,999$833.3K0.00%+149,662+138.1%Added
Sphera Funds Management Ltd.260,385$841.0K0.20%+63,750+32.4%Added
HAP Trading, LLC262,776$848.8K0.23%+262,776New
Balyasny Asset Management LLC286,533$925.5K0.00%+286,533New
Northern Trust Corp378,307$1.22M0.00%+34,326+10.0%Added
Hudson Bay Capital Management LP403,449$1.30M0.01%+174,688+76.4%Added
Jane Street Group, LLC422,712$1.37M0.00%+412,179+3,913.2%Added
Mangrove Partners442,236$1.43M0.12%−327,997−42.6%Reduced
Driehaus Capital Management LLC535,464$1.73M0.01%00.0%Unchanged
AQR Capital Management LLC562,403$1.82M0.00%+133,915+31.3%Added
Verition Fund Management LLC567,683$1.83M0.01%00.0%Unchanged
Renaissance Technologies LLC858,642$2.77M0.00%+296,900+52.9%Added
State Street Corp891,869$2.88M0.00%+32,901+3.8%Added
AIGH Capital Management LLC1,000,000$3.23M1.13%+1,000,000New
Geode Capital Management, LLC1,022,527$3.30M0.00%+118,102+13.1%Added
DAFNA Capital Management LLC1,027,764$3.32M0.82%+656,330+176.7%Added
Point72 Asset Management, L.P.1,223,866$3.95M0.01%+1,223,866New
Caption Management, LLC1,312,352$4.24M0.25%+623,062+90.4%Added
Citadel Advisors LLC1,477,506$4.77M0.00%+141,251+10.6%Added
Goldman Sachs Group Inc1,575,001$5.09M0.00%+1,443,379+1,096.6%Added
Woodline Partners LP1,622,850$5.24M0.02%+1,000,168+160.6%Added
Alyeska Investment Group, L.P.1,887,169$6.10M0.02%−188,713−9.1%Reduced
Adage Capital Partners GP, L.L.C.1,900,000$6.14M0.01%+1,900,000New
Vanguard Group Inc3,087,840$9.97M0.00%+945,809+44.2%Added
RTW Investments, LP3,125,000$10.1M0.12%+3,125,000New
Opaleye Management Inc.3,720,867$10.6M1.49%−389,133−9.5%Reduced
BlackRock, Inc.3,339,192$10.8M0.00%+299,212+9.8%Added
Millennium Management LLC4,896,831$15.8M0.01%+1,241,642+34.0%Added
Blue Owl Capital Holdings LP5,853,040$18.9M5.87%+925,000+18.8%Added
Ra Capital Management, L.P.6,045,351$19.5M0.24%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)30,606,974$98.9M1.52%+9,375,000+44.2%Added
UBS Oconnor LLC0$00.00%−307,198−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−256,861−100.0%Sold out
Wexford Capital LP0$00.00%−69,799−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−31,515−100.0%Sold out
Algert Global LLC0$00.00%−29,030−100.0%Sold out
Keystone Financial Group0$00.00%−13,000−100.0%Sold out
Voya Investment Management LLC0$00.00%−12,092−100.0%Sold out
Raymond James Financial Inc0$00.00%−8,000−100.0%Sold out
GWM Advisors LLC0$00.00%−4,121−100.0%Sold out
HAP Trading, LLC––––Not filed